XML 55 R33.htm IDEA: XBRL DOCUMENT v3.23.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Summary of Fair Value Hierarchy of Financial Liabilities Measured at Fair Value (Details)
Dec. 31, 2022
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Derivative liability
Fair Value, Recurring  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Derivative liability $ (1,585,000)
Total liabilities at fair value 5,380,646
Fair Value, Recurring | Commercial Paper  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Commercial paper 6,965,646
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Derivative liability 0
Total liabilities at fair value 0
Fair Value, Recurring | Quoted Prices in Active Markets for Identical Assets (Level 1) | Commercial Paper  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Commercial paper 0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Derivative liability 0
Total liabilities at fair value 6,965,646
Fair Value, Recurring | Significant Other Observable Inputs (Level 2) | Commercial Paper  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Commercial paper 6,965,646
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Derivative liability (1,585,000)
Total liabilities at fair value (1,585,000)
Fair Value, Recurring | Significant Unobservable Inputs (Level 3) | Commercial Paper  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Commercial paper $ 0